Therapeutic Asset Ratings

464 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Idov-Immune Prostate Cancer	ViroMissile, Inc.	P1	C (36)
Interleukin-12 Gene Non-Small Cell Lung Carcinoma	The Methodist Hospital Research Institute	P1	C (36)
Mem-288 Intratumoral Pancreatic Neoplasm	Memgen, Inc.	P1	C (36)
Mem-288 Intratumoral Neoplasm	Memgen, Inc.	P1	C (36)
Recombinant Human Il-21-Expressing Oncolytic Vaccinia Virus Cancer	Hangzhou Converd Co., Ltd.	P1	C (36)
Sti-1386 Neoplasm	Sorrento Therapeutics, Inc.	P1	C (36)
vrt106 Neoplasm	Guangzhou Virotech Pharmaceutical Co., Ltd.	P1	C (36)
Recombinant L-Ifn Adenovirus Urinary Bladder Carcinoma	Shanghai Fengxian District Central Hospital	Early P1	C (36)
Recombinant L-Ifn Adenovirus Head And Neck Cancer	Shanghai Fengxian District Central Hospital	Early P1	C (36)
Sxrn Cancer	Jiangsu Nutai Biologics Co., Ltd	Early P1	C (36)
Idov-Immune Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Early P1	C (34)
Recombinant L-Ifn Adenovirus Lung Cancer	Shanghai Fengxian District Central Hospital	Early P1	C (34)
Recombinant L-Ifn Adenovirus Melanoma	Shanghai Fengxian District Central Hospital	Early P1	C (34)
Recombinant L-Ifn Adenovirus Breast Cancer	Shanghai Fengxian District Central Hospital	Early P1	C (33)
Anti-Cd19 Gene B-Cell Non-Hodgkin Lymphoma	Anhui Provincial Hospital	N/A	D (30)
DEVAFIDUGENE CIVAPARVOVEC Hemophilia B	Sangamo Therapeutics		D (30)
DEVAFIDUGENE CIVAPARVOVEC Mucopolysaccharidosis Type 2	Sangamo Therapeutics		D (30)
hg204 Syndromic X-Linked Intellectual Disability Lubs Type	HuidaGene Therapeutics Co., Ltd.	N/A	D (30)
Jcxh-213,An Mrna-Lnp Based In Vivo Car Therapy B-Cell Non-Hodgkin Lymphoma	Beijing GoBroad Hospital	N/A	D (30)
Kite-197 Cancer	Kite, A Gilead Company		D (30)
Of Gs001 Gene Therapy	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (30)
Of Gs001 Hemophilia A	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (30)
sb-913 Hemophilia B	Sangamo Therapeutics		D (30)
sb-913 Mucopolysaccharidosis Type 1	Sangamo Therapeutics		D (30)
Sb-Fix Mucopolysaccharidosis Type 1	Sangamo Therapeutics		D (30)

Showing 426 to 450 of 464 assets

PreviousPage 18 of 19Next